Epithelial-mesenchymal transition and tumor-associated macrophage axis in metastatic breast cancer: converging mechanisms and therapeutic perspectives

Life Sciences · 2025-11-18 · 1 citations

Cytoplasmic connexin43-microtubule interactions promote glioblastoma stem-like cell maintenance and tumorigenicity

Cell Death and Disease · 2025-05-16 · 11 citations

Glioblastoma (GBM) is the most common primary tumor of the central nervous system. One major challenge in GBM treatment is the resistance to chemotherapy and radiotherapy observed in subpopulations of cancer cells, including GBM stem-like cells (GSCs). These cells have the capacity to self-renew and differentiate and as such, GSCs participate in tumor recurrence following treatment. The gap junction protein connexin43 (Cx43) has complex roles in oncogenesis and we have previously demonstrated an association between Cx43 and GBM chemotherapy resistance. Here, we report, for the first time, increased direct interaction between non-junctional Cx43 and microtubules in the cytoplasm of GSCs. We hypothesize that non-junctional Cx43/microtubule complexing is critical for GSC maintenance and survival and sought to specifically disrupt this interaction while maintaining other Cx43 functions, such as gap junction formation. Using a Cx43 mimetic peptide of the carboxyl terminal tubulin-binding domain of Cx43 (JM2), we successfully disrupted Cx43 interaction with microtubules in GSCs. Importantly, administration of JM2 significantly decreased GSC survival in vitro, and limited GSC-derived and GBM patient-derived xenograft tumor growth in vivo. Together, these results identify JM2 as a novel peptide drug to ablate GSCs in GBM treatment.

Author Reply to Peer Reviews of Astrocytic connexin43 phosphorylation contributes to seizure susceptibility after mild Traumatic Brain Injury

2025-08-02

Adaptive Responses Directed by CREB Control Epithelial-Mesenchymal Plasticity in Cancer

bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-11

Cellular plasticity plays essential roles in development including organogenesis and tissue homeostasis. The epithelial-to-mesenchymal transition (EMT) is no longer considered a binary switch but rather a dynamic process characterized by a continuum of metastable intermediates having unique features. This epithelial-mesenchymal (E/M) plasticity can be co-opted by cancer cells to promote dedifferentiation that results in hybrid E/M states which increase tumor heterogeneity and generate distinct molecular and phenotypic adaptations that promote drug resistance, dormancy, recurrence, and/or cell invasion and metastasis. The mechanisms that coordinate and maintain metastable hybrid E/M states are poorly understood, and here we report they are controlled by the master transcription factor CREB which regulates adaptive response genes necessary for E/M plasticity. Specifically, a CREB-dependent head and neck cancer model validated the role of CREB in cancer cell plasticity and revealed that it controls a non-canonical EMT gene signature. Moreover, analyses of this signature across cancer types identified the transcriptional regulators VGLL3 and KLF3 as core PanCancer mediators of hybrid E/M states, and gain- and loss-of-function studies established that CREB regulates E/M plasticity by coordinating VGLL3 and KLF3 to drive metastasis.

Optimized enrichment of murine blood–brain barrier vessels with a critical focus on network hierarchy in post-collection analysis

Scientific Reports · 2025-05-06 · 1 citations

Cerebrovascular networks contain a unique region of interconnected capillaries known as the blood-brain barrier (BBB). Positioned between upstream arteries and downstream veins, these microvessels have unique structural features, such as the absence of vascular smooth muscle cells (vSMCs) and a relatively thin basement membrane, to facilitate highly efficient yet selective exchange between the circulation and the brain interstitium. This vital role in neurological health and function has garnered significant attention from the scientific community and inspired methodology for enriching BBB capillaries. Extensive characterization of the isolates from such protocols is essential for framing the results of follow-on experiments and analyses, providing the most accurate interpretation and assignment of BBB properties. Seeking to aid in these efforts, here we visually screened output samples using fluorescent labels and found considerable reduction of non-vascular cells following density gradient centrifugation (DGC) and subsequent filtration. Comparatively, this protocol enriched brain capillaries, though larger diameter vessels associated with vSMCs could not be fully excluded. Protein analysis further underscored the enrichment of vascular markers following DGC, with filtration preserving BBB-associated markers and reducing - though not fully removing - arterial/venous contributions. Transcriptional profiling followed similar trends of DGC plus filtration generating isolates with less non-vascular and non-capillary material included. Considering vascular network hierarchy inspired a more comprehensive assessment of the material yielded from brain microvasculature isolation protocols. This approach is important for providing an accurate representation of the cerebrovascular segments being used for data collection and assigning BBB properties specifically to capillaries relative to other regions of the brain vasculature.

Optimized Enrichment of Murine Blood-Brain Barrier Vessels with a Critical Focus on Network Hierarchy in Post-Collection Analysis

bioRxiv (Cold Spring Harbor Laboratory) · 2024-09-20 · 1 citations

Cerebrovascular networks contain a unique region of interconnected capillaries known as the blood-brain barrier (BBB). Positioned between upstream arteries and downstream veins, these microvessels have unique structural features, such as the absence of vascular smooth muscle cells (vSMCs) and a relatively thin basement membrane, to facilitate highly efficient yet selective exchange between the circulation and the brain interstitium. This vital role in neurological health and function has garnered significant attention from the scientific community and inspired methodology for enriching BBB capillaries. Extensive characterization of the isolates from such protocols is essential for framing the results of follow-on experiments and analyses, providing the most accurate interpretation and assignment of BBB properties. Seeking to aid in these efforts, here we visually screened output samples using fluorescent labels and found considerable reduction of non-vascular cells following density gradient centrifugation (DGC) and subsequent filtration. Comparatively, this protocol enriched brain capillaries, though larger diameter vessels associated with vSMCs could not be fully excluded. Protein analysis further underscored the enrichment of vascular markers following DGC, with filtration preserving BBB-associated markers and reducing - though not fully removing - arterial/venous contributions. Transcriptional profiling followed similar trends of DGC plus filtration generating isolates with less non-vascular and non- capillary material included. Considering vascular network hierarchy inspired a more comprehensive assessment of the material yielded from brain microvasculature isolation protocols. This approach is important for providing an accurate representation of the cerebrovascular segments being used for data collection and assigning BBB properties specifically to capillaries relative to other regions of the brain vasculature. HIGHLIGHTS: We optimized a protocol for the enrichment of murine capillaries using density gradient centrifugation and follow-on filtration.We offer an approach to analyzing post-collection cerebrovascular fragments and cells with respect to vascular network hierarchy.Assessing arterial and venous markers alongside those associated with the BBB provides a more comprehensive view of material collected.Enhanced insight into isolate composition is critical for a more accurate view of BBB biology relative to larger diameter cerebrovasculature. MOTIVATION: The recent surge in studies investigating the cerebrovasculature, and the blood-brain barrier (BBB) in particular, has inspired a broad range of approaches to target and observe these specialized blood vessels within murine models. To capture transcriptional and molecular changes during a specific intervention or disease model, techniques have been developed to isolate brain capillary networks and collect their cellular constituents for downstream analysis. Here, we sought to highlight the benefits and cautions of isolating and enriching microvessels from murine brain tissue. Specifically, through rigorous assessment of the output material following application of specific protocols, we presented the benefits of specific approaches to reducing the inclusion of non-vascular cells and non-capillary vessel segments, verified by analysis of vascular-related proteins and transcripts. We also emphasized the levels of larger- caliber vessels (i.e. arteries/arterioles and veins/venules) that are collected alongside cerebral capillaries with each method. Distinguishing these vascular regions with greater precision is critical for attributing specific characteristics exclusively to the BBB where metabolic, ion, and waste exchange occurs. While the addition of larger vessels to molecular / transcriptional analyses or follow-on experiments may not be substantial for a given protocol, it is essential to gauge and report their level of inclusion, as their contributions may be inadvertently assigned to the BBB. Therefore, we present this optimized brain microvessel isolation protocol and associated evaluation methods to underscore the need for increased rigor in characterizing vascular regions that are collected and analyzed within a given study.

Astrocytic connexin43 phosphorylation contributes to seizure susceptibility after mild traumatic brain injury

bioRxiv (Cold Spring Harbor Laboratory) · 2024-11-14 · 2 citations

Abstract Astrocytes play a crucial role in maintaining brain homeostasis through functional gap junctions (GJs) primarily formed by connexin43 (Cx43) in the cortical gray matter. These GJs facilitate electrical and metabolic coupling between astrocytes, allowing the passage of ions, glucose, and metabolites. Dysregulation of Cx43 has been implicated in various pathologies, including traumatic brain injury (TBI) and acquired epilepsy. After mild TBI/concussion, we previously identified a subset of atypical astrocytes, which are correlated with the development of spontaneous seizures. These astrocytes exhibit reduced Cx43 expression and coupling. However, atypical astrocytes represent a relatively small subset of astrocytes within the cortical gray matter and previous studies suggest an overall increase of Cx43 protein after TBI. Additionally, Cx43 also has non-junctional and channel-independent functions, which include hemichannel communication with the extracellular milieu, cell adhesion, protein trafficking, protein-protein interactions, and intracellular signaling. In the present study, we set out to determine how mild TBI initiates alterations to Cx43 protein expression and localization, how they may be regulated, and whether they contribute to seizure susceptibility. We demonstrate remarkable heterogeneity of Cx43 protein levels from astrocyte to astrocyte. In accordance with our previous findings, a subset of astrocytes lost Cx43 expression, yet total cortical Cx43 protein increased. At the subcellular level, junctional Cx43 protein levels remained stable, while hemichannels and/or cytoplasmic Cx43 were increased. Phosphorylation of Cx43 at serine 368, a key regulatory site influencing GJ assembly and function, increased after mild TBI. Critically, Cx43 S368A mutant mice, lacking this phosphorylation, exhibited reduced susceptibility to pentylenetetrazol-induced seizures. These findings suggest that TBI-induced Cx43 phosphorylation enhances seizure susceptibility, while inhibiting this modification presents a potential therapeutic avenue for mitigating neuronal hyperexcitability and seizure development. Significance statement Connexin43 (Cx43) is the main protein comprising astrocyte gap junctions which mediate astrocyte coupling into cellular networks, but it also has other non-junctional functions. Many pathologies present with altered Cx43 regulation. In this study, we assessed Cx43 alterations after mild traumatic brain injury (TBI) in a mouse model. We found that while some astrocytes lost Cx43 expression, other astrocytes had increased cytoplasmic and hemichannel Cx43. This increase correlated with an increase in phosphorylated Cx43 at serine 368. Cx43 S368A mutant mice, lacking this phosphorylation, exhibited reduced susceptibility to seizures induced by pentylenetetrazol (PTZ). These findings suggest that TBI-induced Cx43 phosphorylation enhances seizure susceptibility.

Increased interaction between connexin43 and microtubules is critical for glioblastoma stem-like cell maintenance and tumorigenicity

bioRxiv (Cold Spring Harbor Laboratory) · 2024-01-27 · 4 citations

Abstract Glioblastoma (GBM) is the most common primary tumor of the central nervous system. One major challenge in GBM treatment is the resistance to chemotherapy and radiotherapy observed in subpopulations of cancer cells, including GBM stem-like cells (GSCs). These cells hold the ability to self-renew or differentiate following treatment, participating in tumor recurrence. The gap junction protein connexin43 (Cx43) has complex roles in oncogenesis and we have previously demonstrated an association between Cx43 and GBM chemotherapy resistance. Here, we report, for the first time, increased direct interaction between non-junctional Cx43 with microtubules in the cytoplasm of GSCs. We hypothesize that non-junctional Cx43/microtubule complexing is critical for GSC maintenance and survival and sought to specifically disrupt this interaction while maintaining other Cx43 functions, such as gap junction formation. Using a Cx43 mimetic peptide of the carboxyl terminal tubulin-binding domain of Cx43 (JM2), we successfully ablated Cx43 interaction with microtubules in GSCs. Importantly, administration of JM2 significantly decreased GSC survival in vitro , and limited GSC-derived tumor growth in vivo . Together, these results identify JM2 as a novel peptide drug to ablate GSCs in GBM treatment.

Acute Adenoviral Infection Elicits an Arrhythmogenic Substrate Prior to Myocarditis

Circulation Research · 2024-02-28 · 18 citations

BACKGROUND: Viral cardiac infection represents a significant clinical challenge encompassing several etiological agents, disease stages, complex presentation, and a resulting lack of mechanistic understanding. Myocarditis is a major cause of sudden cardiac death in young adults, where current knowledge in the field is dominated by later disease phases and pathological immune responses. However, little is known regarding how infection can acutely induce an arrhythmogenic substrate before significant immune responses. Adenovirus is a leading cause of myocarditis, but due to species specificity, models of infection are lacking, and it is not understood how adenoviral infection may underlie sudden cardiac arrest. Mouse adenovirus type-3 was previously reported as cardiotropic, yet it has not been utilized to understand the mechanisms of cardiac infection and pathology. METHODS: We have developed mouse adenovirus type-3 infection as a model to investigate acute cardiac infection and molecular alterations to the infected heart before an appreciable immune response or gross cardiomyopathy. RESULTS: Optical mapping of infected hearts exposes decreases in conduction velocity concomitant with increased Cx43 Ser368 phosphorylation, a residue known to regulate gap junction function. Hearts from animals harboring a phospho-null mutation at Cx43 Ser368 are protected against mouse adenovirus type-3–induced conduction velocity slowing. Additional to gap junction alterations, patch clamping of mouse adenovirus type-3–infected adult mouse ventricular cardiomyocytes reveals prolonged action potential duration as a result of decreased I K1 and I Ks current density. Turning to human systems, we find human adenovirus type-5 increases phosphorylation of Cx43 Ser368 and disrupts synchrony in human induced pluripotent stem cell-derived cardiomyocytes, indicating common mechanisms with our mouse whole heart and adult cardiomyocyte data. CONCLUSIONS: Together, these findings demonstrate that adenoviral infection creates an arrhythmogenic substrate through direct targeting of gap junction and ion channel function in the heart. Such alterations are known to precipitate arrhythmias and likely contribute to sudden cardiac death in acutely infected patients.

Abstract 1235: Quantitative high-content imaging reveals novel modulators of the metastatic hybrid state during epithelial-mesenchymal transition

Cancer Research · 2023-04-04

Abstract Epithelial-mesenchymal transition (EMT) is a normal developmental and healing process that can be pathologically reactivated during cancer progression. Through EMT, neoplastic cells obtain metastatic capabilities like enhanced motility, invasion, and resistance to apoptosis. Recent studies have highlighted dynamic cell plasticity during EMT, including a highly tumorigenic population of cells within the full spectrum of transitions that adopt a partial EMT state. These hybrid populations retain a higher degree of metastatic ability due to the dual nature of their phenotype; however, concomitant expression of epithelial and mesenchymal traits makes characterization and analysis difficult. Additionally, the total expression of certain markers can remain unchanged during EMT while their subcellular localization and function is altered. Therefore, there is a need to improve analytical methods to better characterize hybrid EMT populations and elucidate the genetic modulators that govern advancement along the EMT spectrum. In this study, we provide an optimized method of automated whole-well imaging and analysis for characterization of the EMT spectrum and hybrid phenotypes. We utilized three different TGF-β-induced EMT models. Cell lines cultured in 96-well plates were treated with TGF-β and/or a specific inhibitor of the TGF-β receptor, SB431542, at different times between 30 minutes and 48 hours before fixing and labeling by immunofluorescence. Expression and subcellular localization of TGF-β effectors Smad2/3; epithelial markers E-cadherin, ZO-1, and β-catenin; and mesenchymal markers N-cadherin, fibronectin, and vimentin, were analyzed and quantified using an automated cell imager system and associated analysis software. In addition, nuclei and cell perimeters were identified to analyze protein nuclear translocation and cell size and shape, respectively. Through these studies, we have successfully isolated a hybrid cell subpopulation emerging at 18 hours of TGF-β treatment. These cells display a partial loss of E-cadherin and upregulation of fibronectin that constitutes a unique proteome distinct from that of fully epithelial and mesenchymal populations. Using RNA-interference, we are currently testing 15 candidate genes we previously identified from a microRNA screen on EMT progression and the hybrid state. In summary, we developed and optimized a novel imaging and analysis method for rapid assessment of EMT cell populations, and identification of novel modulators of the EMT spectrum. This method can be more widely applied to screen for small molecules or therapeutic peptides affecting EMT-driven malignancy. Given that the hybrid phenotype is now considered to have higher metastatic characteristics overall, we believe this approach will facilitate identification and testing of potential targets for treatment of metastatic disease. Citation Format: Daniel J. Purcell, Christina E. Wheeler, Stacie E. Deaver, Robert L. Judson-Torres, Samy Lamouille. Quantitative high-content imaging reveals novel modulators of the metastatic hybrid state during epithelial-mesenchymal transition [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1235.